Theranostic Platform News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Theranostic Platform. Real-time updates on events, politics, business and more.

Curasight A/S reports positive preclinical results with uTREAT[®] in lung cancer (NSCLC)

October 18, 2023

Preclinical studies show uTREAT® effective in treating non-small cell lung cancer Data follows recent announcement of positive preclinical results within glioblastoma and supports hypothesis...

Ulrich Krasilnikoff Curasightas Curasight Positron Emissions Tomography Radioligand Therapy Theranostic Platform

Source: marketscreener.com

Y-mAbs Reports Second Quarter 2023 Financial Results and Recent Corporate Developments

August 10, 2023

Q2 2023 DANYELZA® record net product revenues of $20.8 million, driving YoY growth of 112% and a 3% sequential increase compared to Q1 2023Managem...

United States Courtney Dugan Company Self Brazilian Health Regulatory Agency American Association For Cancer Research Company Annual Report On Form

Source: businessinsider.com

Y-mAbs Announces Presentation of GD2-SADA Study at ASCO

May 26, 2023

NEW YORK, May 26, 2023 -- Y-mAbs Therapeutics, Inc. a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for... | May 26, 2023

New York United States Memorial Sloan Kettering Cancer Center Courtney Dugan Massachusetts Institute Of Technology American Society Of Clinical Oncology

Source: marketscreener.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Theranostic Platform News Today

Curasight A/S reports positive preclinical results with uTREAT[&#xAE;] in lung cancer (NSCLC)

Y-mAbs Reports Second Quarter 2023 Financial Results and Recent Corporate Developments

Y-mAbs Announces Presentation of GD2-SADA Study at ASCO

Explore More Categories

Curasight A/S reports positive preclinical results with uTREAT[®] in lung cancer (NSCLC)